Back

Improved reduction of cardiovascular risk by bedtime ingestion of ARB and ACEI medication class therapies

European Heart Journal

16 April 2020
Organised by: Logo
Read full article
ESC Journals HYPERTENSION

Contributors

Ramón C Hermida
Ramón C Hermida

Author

Author

Juan J Crespo
Juan J Crespo

Author

Author

Manuel Domínguez-Sardiña
Manuel Domínguez-Sardiña

Author

Author

You may be interested in
thumbnail
Congress Presentation
Meta-analysis of trials of antihypertensive medication bedtime dosing including individual-patient data from BedMed and BedMed-Frail
31 August 2024
thumbnail
Congress Presentation
Thrombin generation and platelet function in patients on RAAS inhibitors
2 September 2019
thumbnail
Congress Presentation
Age-stratified and sex-stratified effect of angiotensin receptor-neprilysin inhibitor in heart failure with reduced ejection fraction-data from PARADE-HF: nationwide medication adherence study
12 May 2024
thumbnail
Congress Presentation
Single pill regimen improves persistence and leads lo better clinical outcome compared to identical multi pill combination. Results of START, a German claims data analysis
30 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources